Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
scientific article published on 4 May 2017
Author/s
author: Loïc Feuvret, Axel Le Cesne, Jean-Yves Blay, Bruno Chauffert, Olivier Mir, Jacques-Olivier Bay, Florence Duffaud, François Bertucci, Christine Chevreau, Emmanuelle Bompas, Didier Cupissol, Esma Saada-Bouzid, Nicolas Penel
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.